By annette
We are happy to announce that Dr Michael Willis from IHE is presenting a poster at this year’s annual meeting of the Swedish Health Economic Association (SHEA). The poster presents results from a literature review and assessment of published budget impact models (BIMs) for NSCLC. BIMs are an important basis for decision-making and should be …
By annette
The prevalence of pain has long been focused in haemophilia research but depression and anxiety are less studied. A Nordic collaboration has investigated national prescription drug data in more than 3000 Nordic persons with haemophilia and compared data patterns to population controls. The key study finding is a persistently higher use of pain, depression and …
By annette
Diabetes Two studies focusing on people with type 2 diabetes and established cardiovascular disease (eCVD) in Sweden have been published in the medical journal “Diabetes, Obesity and Metabolism”. The first study examines the burden of hospital-based care, work absence, associated costs and excess mortality in people with type 2 diabetes, with and without eCVD. The …
By annette
New global study on the value of precision medicine in oncology. Read more
By annette
In the lates issue of Haemophilia, IHE contributes with a publication on how to make indirect comparisons of FVIII replacement products for treatment of haemophilia A based on the area under the plasma level curve (AUC). Read more
By annette
Researchers from IHE report significant long-term improvements in blood pressure and other risk factors for cardiovascular disease among Swedish patients treated for hypertension via a novel digital therapeutics’ platform. Read more
By annette
In a newly published register study, researcher from IHE have investigated the economic burden of palmoplantar pustulosis (PPP) in Sweden. PPP is a chronic relapsing skin condition commonly occurring in combination with psoriasis vulgaris. Read more